President Volodymyr Zelensky said Monday that Ukraine was ready to de-escalate the war with Russia if its rival did the same, after US President Donald Trump announced that the foes had...
Canada is a safe place to invest "in a very uncertain world," Finance Minister Francois-Philippe Champagne told AFP Monday, ahead of a summit where the country is seeking...
Netherlands striker Donyell Malen scored his sixth goal of the season as Roma moved to the top of the Serie A table with a 2-0 win over Torino on Monday, as Inter beat Udinese 5-3 to keep up with...
Kinaxis® Inc. (TSX:KXS)
, a global leader in AI-powered supply chain planning and orchestration, will bring together some of the world’s most innovative supply chain leaders at Kinexions EMEA 2026 from October 26-28. Building on theoperational orchestration visionKinaxis introduced earlier this year, the conference offers an inside look at how leading organizations are harnessing AI innovation and agentic capabilities to help supply chain...
Cebreo Medical today announced that its NeuroBuds® device has received CE marking, confirming conformity with applicable EU requirements. Unlike conventional EEG systems that require a technician-applied cap of electrodes, NeuroBuds is designed to be used unassisted by the patient at home, enabling multi-day...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced the launch ofChange the Tune in TRD, a new U.S. HCP disease education initiative, to deepen understanding and increase recognition of TRD. The campaign explores the neurobiology of this distinct form of depression...
NIQ (NYSE: NIQ), a leading consumer intelligence company, today announced the launch of Digital Purchase GeoAudiences across five European markets. The new solution extends NIQ’s geographic audience capabilities into digital-first categories including...
QurCan Therapeutics (“QurCan”), a biotechnology company pioneering non-viral, polymer-lipid nanoparticle (PLNP) delivery of genetic medicines through its proprietary TERP™ (Target-Engineered Responsive Polymer) platform, today announced an exclusive research and collaboration agreement with Eli Lilly and Company (“Lilly”) for the treatment of diseases of the...